Drug Patents owned by Dare

1. List of Xaciato drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11129896 DARE Topical formulations and treatments
Sep, 2036

(13 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Dec 7, 2024
Generating Antibiotic Incentives Now (GAIN) Dec 7, 2029

Drugs and Companies using CLINDAMYCIN PHOSPHATE ingredient

Market Authorisation Date: 07 December, 2021

Treatment: Method of treating bacterial vaginosis by single dose administration of a clindamycin pharmaceutical gel formulation

Dosage: GEL;VAGINAL

More Information on Dosage

XACIATO family patents

5

United States

1

Lithuania

1

Hungary

1

Portugal

1

Denmark

1

Canada

1

Spain

1

Mexico

1

Poland

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic